Apyx Medical CorpAPYX
Price$2.45Intrinsic value$3.3537% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $58.4M+21.4% YoYTTM through 30 Jun 2026
Net Income -$8.6MTTM through 30 Jun 2026
Free Cash Flow -$11MTTM through 30 Jun 2026

Margins

Current
Gross Margin63.2%
EBITDA Margin-4.7%
Operating Margin-7.2%
Net Margin-14.8%

Returns

-70.8%ROE
-14.4%ROA

Balance Sheet Health

Debt / Equity2.74x
Current Ratio5.80x
Net Debt$4M
Cash & Equivalents$27.6M

Quality Metrics

Altman Z-Score0.95
Piotroski F-Score3 / 9
FCF Margin-18.9%
Rule of 40-17.2
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $52.8M
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $-0.27

Dividend

No dividend

Capital Allocation

R&D Spend$3.3M
Capex Intensity1.6%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.